Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP266275.RAu8lD5H640l51MdiaCwUZpTJ0PgwSeMVFUgppVojz4_w130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266275.RAu8lD5H640l51MdiaCwUZpTJ0PgwSeMVFUgppVojz4_w130_provenance.
• NP497201.RAgJkj5qKPURJTI8DIyBYHUPpmCgIQw7lDsyfqPsNkaGg130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497201.RAgJkj5qKPURJTI8DIyBYHUPpmCgIQw7lDsyfqPsNkaGg130_provenance.
• NP421978.RA-90kPaW70W85a-m8Nd9IFiYbaUpgtlxXgQ8foufsqCU130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421978.RA-90kPaW70W85a-m8Nd9IFiYbaUpgtlxXgQ8foufsqCU130_provenance.
• NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.
• NP549180.RATbWmQTiQpbYkn2wGoujfwZ34sQATL2m7Bls9q_FJz9U130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549180.RATbWmQTiQpbYkn2wGoujfwZ34sQATL2m7Bls9q_FJz9U130_provenance.
• NP549340.RAamusveNd7nWfsCV7Z1HEzheFCM9tY5R_lBb9wMTox-w130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549340.RAamusveNd7nWfsCV7Z1HEzheFCM9tY5R_lBb9wMTox-w130_provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1046159.RAAskSxIF3Pyi5mjOJwdmF1SgdJZiYm8pLhi_fPe09FAs130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046159.RAAskSxIF3Pyi5mjOJwdmF1SgdJZiYm8pLhi_fPe09FAs130_provenance.
• NP1046161.RAC-uxojsOBgNdD5xRledWiIQUcxXvNWlZPppy2lLHuMc130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046161.RAC-uxojsOBgNdD5xRledWiIQUcxXvNWlZPppy2lLHuMc130_provenance.
• NP1046156.RAgCBTfCd5DFVXlsQE0rqdVGbvqvmOmm0b60Efgi4Qaos130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046156.RAgCBTfCd5DFVXlsQE0rqdVGbvqvmOmm0b60Efgi4Qaos130_provenance.
• NP1046158.RArm7IzJ7yx_nKlKjWqmjfoONFtrBd8MIQD0-QyOy-YW4130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046158.RArm7IzJ7yx_nKlKjWqmjfoONFtrBd8MIQD0-QyOy-YW4130_provenance.
• NP1046160.RAnhST9gasaOE9wHrPAWq_0wkc9927W5Eki69F_i1JR_E130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046160.RAnhST9gasaOE9wHrPAWq_0wkc9927W5Eki69F_i1JR_E130_provenance.
• NP1046163.RAuC0KzpgVHVIFo4iAip9R_g9Ikh-_iQAWLyvuuslLlSc130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046163.RAuC0KzpgVHVIFo4iAip9R_g9Ikh-_iQAWLyvuuslLlSc130_provenance.
• NP251202.RA7Gef_ZGQ8UF3OJmtMK1Ntu-O4qXGIFTsh6C0OVxG2xk130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251202.RA7Gef_ZGQ8UF3OJmtMK1Ntu-O4qXGIFTsh6C0OVxG2xk130_provenance.
• NP549209.RANN_pGBuG5NGZIGv8KFUIlmJ_UZUQ_03Em9w9neshFEY130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549209.RANN_pGBuG5NGZIGv8KFUIlmJ_UZUQ_03Em9w9neshFEY130_provenance.
• NP825840.RANQaA59oGVwVH5-fVqqEAZmEgMhasTaEgadSRm7ePDes130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825840.RANQaA59oGVwVH5-fVqqEAZmEgMhasTaEgadSRm7ePDes130_provenance.
• NP1046157.RAJDWuU6sybFFxGEESsX76I0NNP9ynkb5jd5dF19riCt0130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046157.RAJDWuU6sybFFxGEESsX76I0NNP9ynkb5jd5dF19riCt0130_provenance.
• NP825846.RA_68yS2hAcQAEFxF2ku-K1YOetykxZBcWbyfkJn07Mqg130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825846.RA_68yS2hAcQAEFxF2ku-K1YOetykxZBcWbyfkJn07Mqg130_provenance.
• NP825877.RA5sCMk7wDOzTjOrK3Ik3ankPYorQIL9_ZOX-4-HzmcSw130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825877.RA5sCMk7wDOzTjOrK3Ik3ankPYorQIL9_ZOX-4-HzmcSw130_provenance.
• NP1046162.RA5DBkhziwdtxQaMpvYYEqiE4YCyWvYNG98Kn_mJ-U3Bo130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046162.RA5DBkhziwdtxQaMpvYYEqiE4YCyWvYNG98Kn_mJ-U3Bo130_provenance.
• NP1046164.RA3agnVXMhss8HG0hb0XEHCNEE-goojpk2pemPq9LtEcU130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046164.RA3agnVXMhss8HG0hb0XEHCNEE-goojpk2pemPq9LtEcU130_provenance.